EDDA Technology, Inc., a robotic surgery firm backed by SoftBank Group Corp., is considering a Hong Kong initial public offering to raise about $300 million, according to people familiar with the matter.

China-based EDDA is working with advisers for IPO, which could take place as early as this year, depending on market conditions, the people said.

Deliberations are in the early stages and no final decisions on the size and timing of any listing have been made, according to the people. A representative for EDDA didn’t immediately respond to requests for comment.

EDDA develops precision 3D medical imaging to help physicians plan for surgery, perform operations and conduct post-op evaluations of patients. The company raised $150 million in April in a private funding round led by SoftBank’s Vision Fund 2. Other investors in the fundraise include OrbiMed Advisors and 3W Fund Management.

It plans to use the proceeds of the fundraising on innovation in precision surgery to treat diseases such as cancer, and to further expand in Chinese cities where hospitals need surgical robots, EDDA said in a statement at the time.

Source: https://www.bloomberg.com/news/articles/2021-06-23/softbank-backed-robotics-firm-edda-said-to-weigh-hong-kong-ipo